CTRI/2020/07/026555已完成未知
Active Safety surveillance study in pediatric patients of Childhood onset Nephrotic Syndrome on Rituximab therapy
INSTITUTIONAL RESEARCH FUND0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.Diagnosed cases of childhood onset nephrotic syndrome <=18 years of age, of any gender, who have either received at least one dose of RTX in the last 3 months or shall receive rituximab in our hospital.
- •2.Subjects willing to give written informed consent and comply with study related instructions
排除标准
- •1.Subjects unwilling to give written informed consent and comply with study related instructions.
- •2.Subjects on rituximab therapy for any non-renal indications.
- •3.Subjects who have received the last dose of RTX more than 3 months back.
研究者
相似试验
已完成
不适用
Surveillance towards preventing RSV respiratory infection in paediatricsISRCTN41075797iverpool School of Tropical Medicine2,074
招募中
不适用
Pediatric Alarm Study For Physiologic Monitoring in General WardJPRN-UMIN000033727Department of General Pediatrics, Tokyo Metropolitan Children's Medical Center400
终止
不适用
Surveillance Study of Patients With Newly Diagnosed OsteosarcomaOsteosarcomaNCT01194284Millennium Pharmaceuticals, Inc.25
已完成
不适用
Study of intensive pediatric pharmacovigilance of nimotuzumab for the treatment of malignant glioma tumors.Malignant gliomasRPCEC00000183Centro de Inmunología Molecular (CIM)160
招募中
Unknown
A prospective observational study in child patients with RSV infectioRSV infectionJPRN-jRCT1030230252Ishiwada Naruhiko100